Calgary Scientific Inc. announced that they will be showcasing a new radiology education tool called RadIQ in Calgary Scientific’s booth at the Radiological Society of North America (RSNA) 2015 annual meeting.


November 24, 2015 — The U.S. Food and Drug Administration (FDA) issued a warning this week that hydrophilic and/or hydrophobic coatings commonly used on intravascular medical devices may separate from these devices and potentially cause serious injuries to patients.

November 24, 2015 —The U.S. Court of Appeals has overturned a federal circuit court’s decision in The Medicines Company v. Hospira Inc., supporting the patents claims for bivalirudin (Angiomax). This vacates the court’s earlier decision invalidating the Orange Book patents covering bivalirudin that expire in 2028 (pediatric exclusivity expiring in 2029). 

November 24, 2015 – The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim Pharmaceuticals’ dabigatran (Pradaxa) for the prophylaxis of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have undergone hip replacement surgery. There are an estimated 300,000 total hip replacement surgeries performed in the United States each year. Without preventive anticoagulant treatment, the incidence of DVT ranges from 40 to 60 percent for primary elective hip surgery patients.

A new 3-D computer modeling system may significantly improve a surgeon’s ability to select the best-sized donor heart for children receiving heart transplants, according to research presented at the American Heart Association’s Scientific Sessions 2015.

NaviGate Cardiac Structures Inc. (NCSI) announced that a first-in-human implant of its catheter-guided, mitral-valved stent into a beating heart was performed successfully in a 53-year-old male patient presenting with severe 4+ mitral regurgitation (MR).

CIRS ATOM phantoms are a full line of anthropomorphic, cross sectional dosimetry phantoms designed to investigate organ dose, whole body effective dose as well as verification of delivery of therapeutic radiation doses.

ATOM is the only line of dosimetry phantoms to range in sizes from newborn to adult. Six models are available: newborn, 1-year, 5-year and 10-year old pediatric phantoms as well as adult male and female phantoms.

Boston Heart Diagnostics announced the launch of StatinSmart, an at-home saliva laboratory developed test that analyzes the SLCO1B1 (Solute Carrier Organic Anion Transporter 1B1) gene for a variant known to increase an individual's risk for developing statin-induced myopathy.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now